FDA approval of ICOTYDE™ (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide
Johnson & Johnson
Johnson & Johnson
1 article from Johnson & Johnson indexed by Voice Herald. Below is what Johnson & Johnson covers most and which stories they have contributed to.